2024 Vaistinių preparatų vertinimai
Paraiškos numeris | Vaistinio preparato pavadinimas | Veiklioji medžiaga | TLK-AM-10 | Rekomendacijos pateikimo data |
STV-64A | Venclyxto | Venetoklaksas | C91.1 | |
STV-129 | Vydura | Rimegepantas | G43 | |
STV-130 | Vydura | Rimegepantas | G43 | |
STV-136 | Doreta | Paracetamolis ir Tramadolis | C00–D48, G00–G99, M00–M99, S00–T31 | |
| STV-161 | Aquipta | Atogepantas | G43 | 2024-03-08 |
| STV-105 | Xeljanz | Tofacitinibas | M08 | 2024-04-04 |
| STV-150 | Rinvoq | Upadacitinibas | K50 | 2024-04-05 |
| STV-123 | Saphnelo | Anifrolumabas | M32 | 2024-04-05 |
| STV-100 | Ryeqo | Relugoliksas/estradiolis/noretisterono acetatas | D25 | 2024-04-03 |
| STV-80 | Enhertu | Trastuzumabo derukstekanas | C50 | 2024-06-04 |
| STV-125 | Keytruda | Pembrolizumabas | C50 | 2024-06-04 |
| STV-151 | Enhertu | Trastuzumabo derukstekanas | C50 | 2024-06-27 |
| STV-152 | Enhertu | Trastuzumabo derukstekanas | C50 | 2024-07-02 |
| STV-155 | Paxlovid | Nirmatrelviras/ritonaviras | U07.1; U07.2 | 2024-07-11 |
| STV-154 | Darzalex | Daratumumabas | E85.8; E85.9 | 2024-07-15 |
| STV-95 | Keytruda | Pembrolizumabas | C54.0, C54.1, C54.2. C54.3, C54.8, C54.9 | 2024-07-16 |
| STV-133 | Keytruda | Pembrolizumabas | C50 | 2024-07-16 |
| STV-99A | Vyxeos (atnaujinta) | Daunorubicinas/citarabinas | C92.0, C92.8 | 2024-07-23 |
| STV-139 | Darzalex | Daratumumabas | C90.0 | 2024-07-23 |
| STV-137 | Kimmtrak | Tebentafuspas | C69.3 | 2024-07-23 |
| STV-119 | CABOMETYX | Kabozantinibas | C64 | 2024-07-24 |
| STV-179 | Kaftrio+Kalydeco | Ivakaftoras/Tezakaftoras/Eleksakaftoras ir Ivakaftoras | E84 | 2024-07-24 |
| STV-118 | Keytruda | Pembrolizumabas | C43 | 2024-07-29 |
| STV-132 | Trepulmix | Treprostinilis | I27.2 | 2024-07-29 |
| STV-143 | Jyseleca | Filgotinibas | M05-M06 | 2024-07-30 |
| STV-147 | Rinvoq | Upadacitinibas | K51 | 2024-07-30 |
| STV-114 | Besremi | Ropeginterferonas alfa-2b | D45 | 2024-08-01 |
| STV-107 | Repatha | Evolokumabas | E78, I25.2, I63, I69.3, Z95.1, Z95.5 | 2024-08-02 |
| STV-126 | Trodelvy | Sacituzumabo govitekanas | C50 | 2024-08-30 |
| STV-142 | Jyseleca | Filgotinibas | K51 | 2024-08-30 |
| STV-162 | Omvoh | Mirikizumabas | K51 | 2024-09-26 |
| STV-182 | Metalyse | Tenekteplazė | I63 | 2024-09-26 |
| STV-81A | Keytruda | Pembrolizumabas | C15, C16 | 2024-09-27 |
| STV-93 | Leqvio | Inklisiranas | E78 kartu su I21; I20.0; I25.2; Z95.1; Z95.5; I20.8; I63; I69.3 | 2024-09-27 |
| STV-140 | Keytruda | Pembrolizumabas | C53 | 2024-09-30 |
| STV-153 | Lynparza | Olaparibum | C50 | 2024-09-30 |
| STV-141 | Nubeqa | Darolutamidas | C61 | 2024-09-30 |
| STV-164 | Xadago | Safinamidas | G20 | 2024-09-30 |
| STV-124 | Tukysa | Tukatinibas | C50 | 2024-10-15 |
| STV-170 | Lupkynis | Voklosporinas | M32.1 | 2024-10-16 |
| STV-172 | Ibrance | Palbociklibas | C50 | 2024-10-17 |
| STV-165 | Vabysmo | Faricimabas | E10.34, E11.34 | 2024-10-23 |
| STV-138 | Vabysmo | Faricimabas | H35.3 | 2024-10-23 |
| STV-156 | Delstrigo | Doravirinas/lamivudinas/tenofoviro dizoproksilis | B20-B24 | 2024-10-28 |
| STV-181 | Lorviqua | Lorlatinibas | C34 | 2024-11-14 |
| STV-101A | Reagila | Kariprazino hidrochloridas | F20 | 2024-12-03 |
| STV-145 | Orgovyx | Relugoliksas | C61 | 2024-12-04 |
| STV-157 | Jardiance | Empagliflozinas | N18 | 2024-12-06 |
| STV-163 | Monofer | Geležies (III) derisomaltozė | D50 | 2024-12-09 |
| STV-90 | Opdivo | Nivolumabas | C43 | 2024-12-19 |
| STV-84 | Keytruda | Pembrolizumabas | C18-C20 | 2024-12-19 |
| STV-146 | Vyvgart | Efgartigimodas alfa | G70.0 | 2024-12-19 |
| STV-159 | Kerendia | Finerenonas | N18.1-N18.4 | 2024-12-19 |
| STV-160 | Pluvicto | Liutecio (177Lu) vipivotido tetraksetanas | C61 | 2024-12-19 |
| STV-167 | Kesimpta | Ofatumumabas | G35 | 2024-12-19 |
| STV-174 | Ikervis | Ciklosporinas | H04.1; H16.2 | 2024-12-19 |
| STV-166 | Kinpeygo | Budezonidas | N02.8 | 2024-12-23 |
| STV-171 | Polivy | Polatuzumabas vedotinas | C83.3 | 2024-12-23 |
| STV-177 | Skyrizi | Risankizumabas | K50 | 2024-12-23 |
| STV-183 | Akeega | Niraparibas/Abiraterono acetatas | C61 | 2024-12-23 |
Atnaujinimo data: 2025-01-06